141 related articles for article (PubMed ID: 27199241)
1. The
Kim JI; Kim JW; Park S; Hong SB; Lee DS; Paek SH; Han DH; Cheong JH; Kim BN
J Atten Disord; 2020 Sep; 24(11):1538-1546. PubMed ID: 27199241
[No Abstract] [Full Text] [Related]
2. Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorder.
Kim JI; Kim JW; Park JE; Park S; Hong SB; Han DH; Cheong JH; Choi JW; Lee S; Kim BN
J Psychopharmacol; 2017 Aug; 31(8):1070-1077. PubMed ID: 27624150
[TBL] [Abstract][Full Text] [Related]
3. The effects of GRIN2B and DRD4 gene variants on local functional connectivity in attention-deficit/hyperactivity disorder.
Kim JI; Yoo JH; Kim D; Jeong B; Kim BN
Brain Imaging Behav; 2018 Feb; 12(1):247-257. PubMed ID: 28258362
[TBL] [Abstract][Full Text] [Related]
4. Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample.
Park S; Jung SW; Kim BN; Cho SC; Shin MS; Kim JW; Yoo HJ; Cho DY; Chung US; Son JW; Kim HW
Behav Brain Funct; 2013 Jan; 9():1. PubMed ID: 23295062
[TBL] [Abstract][Full Text] [Related]
5. Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region.
Adams J; Crosbie J; Wigg K; Ickowicz A; Pathare T; Roberts W; Malone M; Schachar R; Tannock R; Kennedy JL; Barr CL
Mol Psychiatry; 2004 May; 9(5):494-9. PubMed ID: 14699423
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of
Myers SJ; Yuan H; Kang JQ; Tan FCK; Traynelis SF; Low CM
F1000Res; 2019; 8():. PubMed ID: 31807283
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of GRIN2A and GRIN2B modify the neurobehavioral effects of low-level lead exposure in children.
Rooney JPK; Woods NF; Martin MD; Woods JS
Environ Res; 2018 Aug; 165():1-10. PubMed ID: 29655037
[TBL] [Abstract][Full Text] [Related]
8. Interaction between lead and noradrenergic genotypes affects neurocognitive functions in attention-deficit/hyperactivity disorder: a case control study.
Choi JW; Jung AH; Nam S; Kim KM; Kim JW; Kim SY; Kim BN; Kim JW
BMC Psychiatry; 2020 Aug; 20(1):407. PubMed ID: 32791971
[TBL] [Abstract][Full Text] [Related]
9. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder.
Dorval KM; Wigg KG; Crosbie J; Tannock R; Kennedy JL; Ickowicz A; Pathare T; Malone M; Schachar R; Barr CL
Genes Brain Behav; 2007 Jul; 6(5):444-52. PubMed ID: 17010153
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD.
Turic D; Langley K; Mills S; Stephens M; Lawson D; Govan C; Williams N; Van Den Bree M; Craddock N; Kent L; Owen M; O'Donovan M; Thapar A
Mol Psychiatry; 2004 Feb; 9(2):169-73. PubMed ID: 14966475
[TBL] [Abstract][Full Text] [Related]
11. Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment.
Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
Pharmacol Rep; 2021 Feb; 73(1):269-277. PubMed ID: 33237434
[TBL] [Abstract][Full Text] [Related]
12. Association between urine phthalate levels and poor attentional performance in children with attention-deficit hyperactivity disorder with evidence of dopamine gene-phthalate interaction.
Park S; Kim BN; Cho SC; Kim Y; Kim JW; Lee JY; Hong SB; Shin MS; Yoo HJ; Im H; Cheong JH; Han DH
Int J Environ Res Public Health; 2014 Jun; 11(7):6743-56. PubMed ID: 24978879
[TBL] [Abstract][Full Text] [Related]
13. Interaction effects of
Kim H; Kim JI; Kim H; Kim JW; Kim BN
Brain Behav; 2017 Sep; 7(9):e00785. PubMed ID: 28948080
[TBL] [Abstract][Full Text] [Related]
14. Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study.
Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
Pharmacol Rep; 2021 Feb; 73(1):309-315. PubMed ID: 33025395
[TBL] [Abstract][Full Text] [Related]
15. Possible association of the alpha-2A-adrenergic receptor gene with response time variability in attention deficit hyperactivity disorder.
Cho SC; Kim JW; Kim BN; Hwang JW; Park M; Kim SA; Cho DY; Yoo HJ; Chung US; Son JW; Park TW
Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):957-63. PubMed ID: 18314873
[TBL] [Abstract][Full Text] [Related]
16. Brain Anatomical Mediators of
Nobile M; Maggioni E; Mauri M; Garzitto M; Piccin S; Bonivento C; Giorda R; Girometti R; Tomasino B; Molteni M; Fabbro F; Brambilla P
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440367
[TBL] [Abstract][Full Text] [Related]
17. [Association of 14 polymorphisms in the five candidate genes and attention deficit hyperactivity disorder].
Gao XP; Su LY; Zhao AL; Luo XR; Xia K
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):617-22. PubMed ID: 19695183
[TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter genotype influences the attention deficit in Korean boys with ADHD.
Oh KS; Shin DW; Oh GT; Noh KS
Yonsei Med J; 2003 Oct; 44(5):787-92. PubMed ID: 14584093
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-d-aspartate (NMDA) receptor genetics: The power of paralog homology and protein dynamics in defining dominant genetic variants.
Charron JG; Hernandez A; Bilinovich SM; Vogt DL; Bedinger LA; Seaver LH; Williams M; Devries S; Campbell DB; Bupp CP; Prokop JW
Am J Med Genet A; 2022 Feb; 188(2):556-568. PubMed ID: 34726335
[TBL] [Abstract][Full Text] [Related]
20. The Utility of the CPT in the Diagnosis of ADHD in Individuals with Substance Abuse: A Systematic Review.
Slobodin O
Eur Addict Res; 2020; 26(4-5):283-294. PubMed ID: 32535592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
